Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/OTT.S95470 http://scihub22266oqcxt.onion/10.2147/OTT.S95470 C4689260!4689260!26719706     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Onco+Targets+Ther 2015 ; 8 (ä): 3783-92 Nephropedia Template TP {{tp|p=26719706|t=2015. The role of CD44 in epithelial?mesenchymal transition and cancer development |pdf=|usr=}}{{26719706}} gab.com Text The role of CD44 in epithelial mesenchymal transition and cancer development JO: Onco Targets Ther http://www.kidney.de/pget.php?&tw=1&pmid=26719706 #FOAvip CD44, a multi-structural and multifunctional transmembrane glycoprotein, was initially identified as a receptor for hyaluronan that participates in both physiological and pathological processes. CD44 is found to be closely linked to the development of various solid tumors. Molecular studies have revealed that high CD44 expression was correlated with the phenotypes of cancer stem cells and epithelial?mesenchymal transition, thereby contributing to tumor invasion, metastasis, recurrence, and chemoresistance. Correspondingly, blockade of CD44 has been demonstrated to be capable of attenuating the malignant phenotype, slowing cancer progression, and reversing therapy resistance. Clinical analyses showed that high CD44 expression is associated with poor survival of various cancer patients, indicating that CD44 can be a potential prognostic marker. In this review, we summarize recent research progress of CD44 on tumor biology and the clinical significance of CD44. Twit Text FOAVip The role of CD44 in epithelial mesenchymal transition and cancer development ????Onco Targets Ther http://www.kidney.de/pget.php?&tw=1&pmid=26719706 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26719706 #FOAvip English Wikipedia <ref>{{Cite pmid|26719706}}</ref> The role of CD44 in epithelial?mesenchymal transition and cancer development #MMPMID26719706 Xu H; Tian Y; Yuan X; Wu H; Liu Q; Pestell RG; Wu K Onco Targets Ther 2015[]; 8 (ä): 3783-92 PMID26719706show ga CD44, a multi-structural and multifunctional transmembrane glycoprotein, was initially identified as a receptor for hyaluronan that participates in both physiological and pathological processes. CD44 is found to be closely linked to the development of various solid tumors. Molecular studies have revealed that high CD44 expression was correlated with the phenotypes of cancer stem cells and epithelial?mesenchymal transition, thereby contributing to tumor invasion, metastasis, recurrence, and chemoresistance. Correspondingly, blockade of CD44 has been demonstrated to be capable of attenuating the malignant phenotype, slowing cancer progression, and reversing therapy resistance. Clinical analyses showed that high CD44 expression is associated with poor survival of various cancer patients, indicating that CD44 can be a potential prognostic marker. In this review, we summarize recent research progress of CD44 on tumor biology and the clinical significance of CD44. äThe role of CD44 in epithelial?mesenchymal transition and cancer devel(epmc).pdf DeepDyve Pubget Overpricing